Cellular Stress &
mTOR Signaling
Cells must balance anabolic protein synthesis (mTOR) with stress survival and protein folding. Transcriptomics allows us to monitor the molecular defense systems that protect cells from physiological, thermal, and oxidative stress.
Tracking Cellular Adaptation
When cells encounter metabolic or physiological stressors, they halt general protein synthesis and activate targeted protein folding systems. Sustained stress can overwhelm protein folding capacity in the endoplasmic reticulum; in most cases the response resolves adaptively.
Tracking the HSP70 and HSP90 chaperone genes alongside the integrated stress response transcripts ATF4 and DDIT3 describes which stress programmes are being transcribed. MTOR transcript level is not a readout of mTORC1 activity: the pathway is controlled by protein phosphorylation and lysosomal recruitment, not by how much MTOR mRNA is present (PMID 28283069). This panel reads the chaperone and integrated stress response genes downstream of it.
Key Pathway Targets
Mechanistic Target of Rapamycin Kinase
Central coordinator of cell growth, protein synthesis, and metabolic signaling.
AMP-Activated Protein Kinase
Kinase that suppresses anabolic pathways under energy stress. It is switched on by nucleotide binding and phosphorylation, so its transcript level does not report its activation state.
Heat Shock Proteins (HSP70 / HSP90)
Molecular chaperones that protect cellular proteins from denaturation during stress.
Integrated Stress Response Markers
Integrated stress response markers. ATF4 is the convergence point for four different stress kinases, only one of which is ER-specific, so these transcripts do not identify which stress is present (PMID 27629041).
Why DNA Tells Only Half the Cellular Stress Story
Your static DNA codes for structural variations in cellular chaperone proteins and heat shock complexes, indicating your inherited vulnerability to physiological or temperature stress. However, static genetic profiles do not show how your cells are actively adapting to current daily stress.
Transcriptomics (RNA) measures gene expression as it is happening. Because transcription responds to conditions rather than inheritance, a transcript panel reflects the state of these genes at the moment the sample was taken.
Protein Panels vs. Transcriptomics
Traditional stress testing relies on adrenal cortisol hormone measurements. Transcriptomics directly quantifies the intracellular pathways coordinates cell survival, protein synthesis, and folding machinery.
| Protein Marker | What It Measures | RNA Target |
|---|---|---|
| Salivary Cortisol | Measures adrenal output; highly unstable and influenced by transient events. | HSPA1A / HSP90AA1 |
| Heat Shock Antibodies | Reflects late-stage immune recognition of tissue strain, not active folding. | MTOR |
| Serum Amino Acids | Indicates metabolite pool availability, not cellular protein translation rate. | ATF4 / DDIT3 |
WHAT A TRANSCRIPTIONAL PANEL DOES NOT TELL YOU
- × That you have, or do not have, any medical condition. This panel reports gene activity, not diagnoses.
- × Whether a therapy is working. Transcript levels move for many reasons — sleep, a recent infection, the time of day, how long since you last ate or trained — and a change in them is not evidence that any intervention succeeded or failed.
- × What your results will be next month. Every value describes the moment the sample was drawn. Single-timepoint transcript measurements carry substantial within-person variability.
- × What is happening in a tissue the sample did not come from. These panels run on a blood sample. A blood transcript level is not a muscle, liver, brain or adipose measurement.
Two Stress Systems, Running Separately
Cellular survival requires balancing anabolic growth (mTOR) with stress adaptation and recycling (AMPK). When cells experience environmental or physiological stressors, they halt protein synthesis and initiate chaperone recruitment to fold damaged proteins.
Anabolic Signaling
Growth signals activate mTORC1 through Rheb and the Rag GTPases at the lysosome, without changing MTOR transcript level (PMID 28283069).
Stress Inactivation
Energy stress activates AMPK by AMP binding and Thr172 phosphorylation, which suppresses mTORC1 and initiates autophagy (PMIDs 22436748, 21258367). The chaperone response in step 04 is triggered separately, by proteotoxic stress.
ER Stress Sensor
Stress raises ATF4 protein without a transcriptional step: phosphorylated eIF2α lets ribosomes bypass an inhibitory upstream open reading frame in the ATF4 message (PMID 15277680).
Chaperone Production
HSF1 induces HSP70 and HSP90 family chaperone genes to refold proteins (PMID 28852220). Separately, sustained integrated stress response signaling induces DDIT3 (CHOP) downstream of ATF4 (PMID 32457508).
Stimulating Intracellular Chaperones
These interventions apply controlled thermal and chemical stressors to trigger the transcription of molecular chaperones, enhancing stress resilience.
Sauna & Heat Therapy
Triggers HSF1 activation, which induces HSP70 and HSP90 family chaperone genes (PMID 28852220). HSF1 itself is regulated by protein-level release from chaperone repression and is not on this panel.
Sauna Alternated with Cold Exposure
Alternating heat and cold exposure has been studied for effects on stress-response signaling. This panel carries no adrenergic target, so that component is not measured here.
Adaptogenic Phytochemicals
Rhodiola and Ashwagandha are studied for effects on stress physiology. Glucocorticoid receptor stabilisation is not an established mechanism for either, and no glucocorticoid target gene is on this panel.
Caloric Cycling
Brief fasting intervals suppress mTORC1 activity. Autophagy is then initiated by dephosphorylation of ULK1 and TFEB, which is a protein-level event (PMID 21258367).
Therapies That Act on These Pathways
These therapies act on genes this panel reports. Biomeme does not prescribe, supply, recommend or evaluate any of them, and listing one here is not a claim that it works. Several are available only by prescription; some are not approved for any use. Where the published evidence is thin or points the other way, the card says so.
BPC-157
Not approved for any useStudied in preclinical models for effects on tissue repair signaling. Not approved for any use, and there are no published human trials.
DSIP
Not approved for any useStudied for effects on sleep architecture. Not approved for any use, and there are no published human trials. This panel carries no cortisol or glucocorticoid target.
Semax
Not approved for any useA peptide registered in Russia and Ukraine and not approved in the United States. This panel carries no BDNF target.
Scientific Citations
- [1] Vattem KM, Wek RC. Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc Natl Acad Sci U S A. 2004;101(31):11269-11274.
- [2] Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132-141.
- [3] Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012;13(4):251-262.
- [4] Pakos-Zebrucka K, Koryga I, Mnich K, et al. The integrated stress response. EMBO Rep. 2016;17(10):1374-1395.
- [5] Saxton RA, Sabatini DM. mTOR Signaling in Growth, Metabolism, and Disease. Cell. 2017;168(6):960-976.
- [6] Gomez-Pastor R, Burchfiel ET, Thiele DJ. Regulation of heat shock transcription factors and their roles in physiology and disease. Nat Rev Mol Cell Biol. 2018;19(1):4-19.
- [7] Hetz C, Zhang K, Kaufman RJ. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol. 2020;21(8):421-438.
The Biomeme Molecular Ecosystem
From deep whole-transcriptome sequencing in the laboratory to rapid point-of-care instrumentation in the field.
High-Depth RNA Sequencing
Processed at One Health Labs, Biomeme's CLIA-certified laboratory, using Illumina NovaSeq high-depth paired-end RNA sequencing. Samples are collected in venous PAXgene blood RNA tubes to stabilize cellular transcription at the moment of draw.
Biomeme/5 Handheld Platform
Beyond central-lab genomics, Biomeme engineers patented, battery-powered real-time PCR instruments. Our deployable hardware brings decentralized molecular detection directly to the field and clinical points of care.
Curious how we measure this?
Learn about the foundational science of Transcriptomics and how Biomeme brings molecular profiling to the point of need.
Ready to Learn More?
Explore how Biomeme's capabilities are being deployed across the Wellness landscape.
ABOUT THESE PANELS
Biomeme's wellness transcriptomic panels are general wellness products. They report gene activity to support a healthy lifestyle. They are not intended to diagnose, treat, cure, mitigate or prevent any disease or condition, and they are not a substitute for evaluation by a licensed healthcare professional. Results describe the state of the measured transcripts at the moment the sample was taken.